Skip to main content
. 2020 Nov 4;112(1):339–346. doi: 10.1111/cas.14706

Figure 2.

Figure 2

Kaplan‐Meier curves of overall survival (A) and progression‐free survival (B) of patients with head and neck squamous cell carcinoma treated with nivolumab according to the Eosinophil Prognostic Score